Meme Kanseri Epidemiyolojisi
Özet
Meme kanseri ülkemizde insidansı artan ve gelecekte de önem arz edecek mortalite nedenlerindendir. Tüm dünyada olduğu gibi ülkemizde de tarama faaliyetleri önemle yürütülmekte olup mortalitenin azaltılması açısından değerlidir. Çeşitli risk faktörleri tanımlanmış olsa da yaş, cinsiyet ve genetik faktörler en bilinenleridir.
Breast cancer is one of the causes of mortality with an increasing incidence in our country and will be important in the future. Screening activities are carried out with great importance in our country, as well as all over the world. Screening activities are valuable in terms of reducing mortality. Although various risk factors have been identified, age, gender and genetic factors are the most well-known.
Referanslar
International Agency for Research on Cancer (IARC) 2022 Globocan (https://gco.iarc.fr/en).
Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Kanser Dairesi Başkanlığı 2018 yılı Türkiye Kanser İstatistikleri (https://hsgm.saglik.gov.tr/depo/birimler/kanser-db/Dokumanlar/Istatistikler/Kanser_Rapor_2018.pdf).
Özmen V. Türkiye'de Meme Kanseri: Klinik ve Histopatolojik Özellikler (13.240 Olgunun Analizi). Meme Sagligi Dergisi/Journal of Breast Health: 2014;10(2).
Kato, I., Tominaga, S., & Suzuki, T. (1988). Factors related to late menopause and early menarche as risk factors for breast cancer. Japanese journal of cancer research, 79(2), 165-172.
Britt, K., Ashworth, A., & Smalley, M. (2007). Pregnancy and the risk of breast cancer. Endocrine-related cancer, 14(4), 907-933.
Chen, C. L., Weiss, N. S., Newcomb, P., Barlow, W., & White, E. (2002). Hormone replacement therapy in relation to breast cancer. Jama, 287(6), 734-741.
Collaborative Group on Hormonal Factors in Breast Cancer. (1996). Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. The Lancet, 347(9017), 1713-1727.
Salman, M. C., Gültekin, M., Taşkıran, Ç., & Ayhan, A. (2005). Hormon ve meme. Türk Jinekolojik Onkoloji Dergisi, 8(2), 37-53.
Winters, S., Martin, C., Murphy, D., & Shokar, N. K. (2017). Breast cancer epidemiology, prevention, and screening. Progress in molecular biology and translational science, 151, 1-32.
McCormack, V. A., & dos Santos Silva, I. (2006). Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiology Biomarkers & Prevention, 15(6), 1159-1169.
Balmana, J., Diez, O., Rubio, I. T., & Cardoso, F. (2011). BRCA in breast cancer: ESMO Clinical Practice Guidelines. Annals of Oncology, 22, vi31-vi34.
Cavanagh, H., & Rogers, K. M. (2015). The role of BRCA1 and BRCA2 mutations in prostate, pancreatic and stomach cancers. Hereditary cancer in clinical practice, 13, 1-7.
